glp-1 3mg Medicare will start covering weight-loss drugs this summer 1 receptor agonists (glucagon GLP-1S TABLETS (25pc) – Vida

Waser B, et al

Further clinical evidence is needed to clarify their role, optimise treatment strategies, and assess their impact on disease progression and patient outcomes

Strong, Foundation for Prader-Willi Research, United States Matteo Spaziani, Sapienza University of Rome, Italy Gerthe Femke Kerkhof, Erasmus Medical Center, Netherlands Updates Copyright 2024 Madeo, Zagaroli, Vandelli, Calcaterra, Crin, De Sanctis, Faienza, Fintini, Guazzarotti, Licenziati, Mozzillo, Pajno, Scarano, Street, Wasniewska, Bocchini, Bucolo, Buganza, Chiarito, Corica, Di Candia, Francavilla, Fratangeli, Improda, Morabito, Mozzato, Rossi, Schiavariello, Farello, Iughetti, Salpietro, Salvatoni, Giordano, Grugni and Delvecchio

JAMA 331, 3848

Tirzepatide mitigates Stroke-Induced Blood-Brain barrier disruption by modulating Claudin-1 and C/EBP- pathways

Basically, it is not possible to tell whether any weight loss that occurred was due to berberine or disease